Immunome

IMNMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.128 B

$18.04 -7.61%

Close of 6 Nov 2026

As of 6 Nov 2026, Immunome (IMNM) has a market capitalization of $2.13B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$6.94M

#3204 by revenue

Earnings

-$212.4M

Loss-making

Shares outstanding

113,577,629

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#91Aurinia PharmaceuticalsAUPH$2.17B
#92SchrodingerSDGR$2.16B
#93ImmunomeIMNM$2.13B
#94Prestige Consumer HealthcarePBH$2.11B
#95BiohavenBHVN$2.09B

What if Immunome were worth as much as…

Open the what-if tool →

Gold $28.2T

$239,289.22

Per share 13,268× higher

Bitcoin $1.53T

$12,947.52

Per share 718× higher

Apple $5.02T

$42,505.51

Per share 2,357× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Immunome are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.